Brain Scientific Stock Performance
| BRSF Stock | USD 0.75 0.00 0.00% |
On a scale of 0 to 100, Brain Scientific holds a performance score of 3. The firm shows a Beta (market volatility) of -1.86, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Brain Scientific are expected to decrease by larger amounts. On the other hand, during market turmoil, Brain Scientific is expected to outperform it. Please check Brain Scientific's standard deviation, as well as the relationship between the maximum drawdown and day median price , to make a quick decision on whether Brain Scientific's price patterns will revert.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Brain Scientific are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Brain Scientific reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 68.9 K | |
| Total Cashflows From Investing Activities | -58.6 K |
Brain |
Brain Scientific Relative Risk vs. Return Landscape
If you would invest 75.00 in Brain Scientific on April 28, 2025 and sell it today you would earn a total of 0.00 from holding Brain Scientific or generate 0.0% return on investment over 90 days. Brain Scientific is currently generating 0.619% in daily expected returns and assumes 12.2741% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Brain, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Brain Scientific Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Brain Scientific's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Brain Scientific, and traders can use it to determine the average amount a Brain Scientific's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0504
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BRSF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 12.27 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.62 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Brain Scientific is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Brain Scientific by adding it to a well-diversified portfolio.
Brain Scientific Fundamentals Growth
Brain Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Brain Scientific, and Brain Scientific fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Brain Pink Sheet performance.
| Return On Equity | -45.97 | |||
| Return On Asset | -1.17 | |||
| Operating Margin | (28.77) % | |||
| Current Valuation | 12.28 M | |||
| Shares Outstanding | 105.4 M | |||
| Price To Sales | 26.56 X | |||
| Revenue | 265.75 K | |||
| EBITDA | (8.32 M) | |||
| Cash And Equivalents | 3.54 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 9.97 M | |||
| Debt To Equity | 0.18 % | |||
| Book Value Per Share | 0.07 X | |||
| Cash Flow From Operations | (5.87 M) | |||
| Earnings Per Share | (0.29) X | |||
| Total Asset | 13.38 M | |||
About Brain Scientific Performance
By analyzing Brain Scientific's fundamental ratios, stakeholders can gain valuable insights into Brain Scientific's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Brain Scientific has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Brain Scientific has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Brain Scientific Inc., a medtech company, provides neurology-focused medical devices and electric motors in the United States. Brain Scientific Inc. was founded in 2013 and is headquartered in Sarasota, Florida. Brain Scientific operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 28 people.Things to note about Brain Scientific performance evaluation
Checking the ongoing alerts about Brain Scientific for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Brain Scientific help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Brain Scientific is way too risky over 90 days horizon | |
| Brain Scientific has some characteristics of a very speculative penny stock | |
| Brain Scientific appears to be risky and price may revert if volatility continues | |
| Brain Scientific currently holds 9.97 M in liabilities with Debt to Equity (D/E) ratio of 0.18, which may suggest the company is not taking enough advantage from borrowing. Brain Scientific has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Brain Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, Brain Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Brain Scientific sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Brain to invest in growth at high rates of return. When we think about Brain Scientific's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 265.75 K. Net Loss for the year was (9.1 M) with profit before overhead, payroll, taxes, and interest of 83.23 K. | |
| Brain Scientific currently holds about 3.54 M in cash with (5.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Roughly 24.0% of Brain Scientific shares are held by company insiders | |
| Latest headline from news.google.com: Tenon Medical Inc. Stock Analysis and Forecast - Free Investment Timing Strategies - PrintWeekIndia |
- Analyzing Brain Scientific's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Brain Scientific's stock is overvalued or undervalued compared to its peers.
- Examining Brain Scientific's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Brain Scientific's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Brain Scientific's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Brain Scientific's pink sheet. These opinions can provide insight into Brain Scientific's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Brain Pink Sheet analysis
When running Brain Scientific's price analysis, check to measure Brain Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brain Scientific is operating at the current time. Most of Brain Scientific's value examination focuses on studying past and present price action to predict the probability of Brain Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brain Scientific's price. Additionally, you may evaluate how the addition of Brain Scientific to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |